Record-Breaking Price Movement
On 9 September 2026, India Glycols Ltd’s share price surged to an intraday high of Rs.307, marking a new 52-week and all-time peak. The stock closed the day with a notable gain of 3.99%, outperforming the broader Sensex index, which declined by 0.69% on the same day. This price level represents a remarkable appreciation from the 52-week low of Rs.171.49, indicating a substantial 77.82% increase from the lowest point in the past year.
The stock has demonstrated strong momentum, registering gains for six consecutive trading sessions and delivering a cumulative return of 27.29% during this period. This rally has outpaced the commodity chemicals sector by 4.29% on the day, underscoring India Glycols’ relative strength within its industry.
Long-Term Performance and Market Capitalisation
India Glycols Ltd is classified as a small-cap company within the commodity chemicals sector. Its market capitalisation grade reflects this status, yet the stock’s performance over various time horizons has been impressive. Over the past year, the stock has appreciated by 70.54%, significantly outperforming the Sensex, which declined by 7.45% during the same period. Year-to-date returns stand at 38.55%, compared to the Sensex’s negative 11.93%.
Looking further back, the company’s three-year and five-year returns have been exceptional, at 278.01% and 307.35% respectively, dwarfing the Sensex’s corresponding gains of 12.70% and 28.73%. Over a decade, India Glycols Ltd’s stock price has multiplied by an extraordinary 2504.81%, compared to the Sensex’s 160.63% increase, highlighting the company’s sustained value creation over the long term.
Technical Indicators and Market Sentiment
The technical outlook for India Glycols Ltd remains bullish. The current trend shifted from sideways to bullish on 4 September 2026 at a price level of Rs.266. The stock is trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling strong upward momentum.
Key technical indicators reinforce this positive stance. Weekly and monthly MACD readings are bullish, as are Bollinger Bands and Dow Theory signals. The Relative Strength Index (RSI) shows a bearish signal on the weekly chart but no definitive signal on the monthly timeframe. The stock’s immediate support is anchored at the 52-week low of Rs.171.49, while the major resistance levels previously at Rs.230.32 (100 DMA) and Rs.249.33 (20 DMA) have been decisively surpassed.
Valuation Metrics and Dividend Yield
At the current price of approximately Rs.305, India Glycols Ltd trades at a price-to-earnings (P/E) ratio of 6 times on a trailing twelve months (TTM) basis, which is relatively low and may indicate undervaluation relative to earnings. The price-to-book value (P/BV) stands at 0.67 times, while the enterprise value to EBITDA ratio is 5.39 times, suggesting the stock is trading at modest valuation multiples within its sector.
The company offers a high dividend yield of 4.13%, with the latest dividend declared at Rs.1.62 per share and a payout ratio of 13.41%. The ex-dividend date was 23 March 2026. This dividend yield is attractive for income-focused investors, especially in the context of the stock’s strong price appreciation.
Financial and Quality Assessment
India Glycols Ltd’s financial performance exhibits a positive short-term trend as of June 2026. The company reported its highest quarterly net sales at ₹1,130.39 crores and a profit before tax (excluding other income) of ₹122.50 crores. Quarterly profit after tax (PAT) reached a peak of ₹96.83 crores, with earnings per share (EPS) at ₹14.45, the highest recorded in recent quarters.
Return on capital employed (ROCE) for the half-year period stood at 11.79%, the highest in recent times, while the operating profit to interest coverage ratio reached 6.73 times, indicating improved ability to service debt. The debt-to-equity ratio was at a low 0.58 times, reflecting a conservative capital structure. However, cash and cash equivalents were at a low ₹49.83 crores, which is the lowest in recent half-year periods.
Quality metrics classify India Glycols Ltd as a below-average quality company based on long-term financial performance. Growth rates over five years show sales increasing at a compound annual growth rate (CAGR) of 8.63% and EBIT growing at 18.75%. The company maintains moderate leverage with an average net debt to equity ratio of 0.56 and average debt to EBITDA of 3.55. Return on equity (ROE) and ROCE averages are modest at 8.69% and 8.60% respectively. Institutional holdings are relatively low at 7.46%, and there is no promoter share pledging.
Trading Volumes and Volatility
Trading activity has been robust, with delivery volumes increasing by 56.02% over the past month and a 98.65% rise in delivery volume on the day compared to the five-day average. The stock experienced high intraday volatility of 154.18%, reflecting active trading and investor engagement around the new price levels.
Summary of Recent Rating Changes
MarketsMOJO upgraded India Glycols Ltd’s Mojo Grade from Sell to Hold on 4 September 2026, reflecting improved market sentiment and company fundamentals. The current Mojo Score stands at 60.0, indicating a neutral stance on the stock’s near-term outlook.
Conclusion
India Glycols Ltd’s stock reaching an all-time high of Rs.307 on 9 September 2026 marks a significant achievement for the company and its shareholders. Supported by strong price momentum, favourable technical indicators, attractive dividend yield, and solid financial results, the stock has demonstrated resilience and growth over multiple timeframes. While quality metrics suggest room for improvement, the company’s consistent sales and earnings growth, coupled with prudent capital management, have underpinned this milestone. The stock’s performance relative to the Sensex and its sector highlights its standout position in the commodity chemicals industry.
